<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is etiologically associated with Epstein-Barr virus (EBV) </plain></SENT>
<SENT sid="1" pm="."><plain>EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> display two latent forms of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>One is referred to as latency I <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, in which EBV expresses the virus genome maintenance protein EBNA1 as the only <z:mp ids='MP_0001799'>viral</z:mp> protein </plain></SENT>
<SENT sid="3" pm="."><plain>The other is referred to as Wp-restricted latency and was recently identified in a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, EBV expresses EBNA1, EBNA3A, EBNA3B, EBNA3C, a truncated form of EBNA-LP, and the <z:mp ids='MP_0001799'>viral</z:mp> Bcl-2 homologue BHRF1, <z:hpo ids='HP_0000001'>all</z:hpo> of which are driven by the BamHI W promoter (Wp) </plain></SENT>
<SENT sid="5" pm="."><plain>To investigate the role of EBV in Wp-restricted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, we conditionally expressed a dominant-negative EBNA1 (dnEBNA1) mutant which interrupts the virus genome maintenance function of EBNA1 in the P3HR-1 BL cell line </plain></SENT>
<SENT sid="6" pm="."><plain>Induction of dnEBNA1 expression caused loss of the EBV genome and resulted in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of P3HR-1 cells in the absence of exogenous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inducers, indicating that P3HR-1 cells cannot survive without EBV </plain></SENT>
<SENT sid="7" pm="."><plain>Stable transfection of the BHRF1 gene into P3HR-1 cells rescued the cells from the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by dnEBNA1 expression, whereas stable transfection of truncated EBNA-LP, EBNA3A, or EBNA3C did not </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, knockdown of BHRF1 expression in P3HR-1 cells resulted in increased cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that EBV is essential for the survival of P3HR-1 cells and that BHRF1 functions as a survival factor </plain></SENT>
<SENT sid="10" pm="."><plain>Our finding implies a critical contribution of BHRF1 to the pathogenesis of Wp-restricted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> </plain></SENT>
</text></document>